Ironwood Pharmaceuticals, Inc.
IRWD
$3.73
$0.236.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,259.11% | -185.59% | 96.93% | 100.09% | 99.74% |
| Total Depreciation and Amortization | -6.48% | -4.91% | 9.71% | 27.68% | 45.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.71% | -14.71% | -92.06% | -91.38% | -91.35% |
| Change in Net Operating Assets | -373.53% | -272.15% | -52.80% | -103.70% | 12.25% |
| Cash from Operations | -45.49% | -79.57% | -47.03% | -43.55% | -45.25% |
| Capital Expenditure | 90.08% | 87.31% | 67.99% | 47.99% | -908.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 99.61% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.19% | 99.82% | 99.99% | 99.99% | 99.58% |
| Total Debt Issued | -100.00% | -100.00% | -62.50% | -62.50% | -62.50% |
| Total Debt Repaid | 94.55% | 87.69% | -92.00% | -165.00% | -266.67% |
| Issuance of Common Stock | -97.48% | -97.49% | -92.30% | 73.24% | 44.62% |
| Repurchase of Common Stock | 100.00% | 100.00% | 80.36% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.69% | 91.65% | 92.31% | 92.31% | -1,166.14% |
| Cash from Financing | 89.65% | 78.02% | -135.48% | -138.60% | -143.22% |
| Foreign Exchange rate Adjustments | -539.81% | -723.75% | -117.24% | 39.62% | -3,333.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 324.49% | 82.18% | 97.90% | 99.36% | 94.99% |